The Festival of Biologics is a one-stop solution for pharma & biotech, academics and research institutes coming together with their partners across the value chain. It includes discoveries on biological drugs, their development and manufacturing, as well as the pricing & market access. Europe's highly anticipated biological conference will be held as a fully onsite event from 2-4 November, 2022, at the Congress Centre, Basel.
DelveInsight’s attendance will serve as an excellent opportunity to build strong global network connection. As the event is mainly targeting antibodies, immunotherapy and biosimilars, the extensive coverage will aid in creating highly advanced technical, market & forecast, pipeline reports containing all the exclusive information.
Our research team will be covering the latest developments of antibody-based therapeutics and related biologics in a very high-quality meeting with excellent talks, great networking opportunities and forums for discussing topical industry issues. The participants in the event will share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market. With this plethora of information, we will be updating our analysis in reports to include the breakthrough data.
Schedule A One-To-One Meeting with Our Delegates At Festival of Biologics, 2022 in Basel on 2nd to 4th November, 2022.
Meet us simply by filling up the form on the right.
DelveInsight’s Immunotherapy Portfolio Management services provide exceptionally unmatched assistance in understanding competencies in the immunotherapy market. In addition to that, we prioritize strategic goals, assess the changes in the immunotherapy industry, understand the current needs of the immunotherapy market and likewise work on creating value for client services.
DelveInsight’s Biosimilars analytical reports provide comprehensive insights on the marketed and pipeline drugs, and data on all the key biosimilar companies involved. Biosimilar reports cover the marketed and pipeline drug profiles, including clinical and nonclinical stage products, therapeutics assessment, route of administration, and molecule type.
DelveInsight aims at providing effective reports that tally with the rare cancer market. Our analysts track developmental, regulatory & commercial milestones of competitor products. It includes aspects such as conference assessment, and company and R&D development assessment to carry out the desired development of oncological products for commercial purposes dealing with the client’s area of interest.
Our multidimensional, purposeful, and credible consultancy services will help in accelerating oncology product services, it includes aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, diagnostic landscape assessment to overcome several challenges in the oncology market.
We have a specialized primary Competitive Intelligence research team that has expertise in the field of oncology. It constitutes analysts, senior analysts, and managers. Our CI force provides the best possible opportunities and most accurate intelligence that can be accumulated and provided to our partners. In addition, exceptionally well and a collection of cancer data with a fundamental goal of acquiring best-in-class intelligence and providing oncology analysis with respect to different cancer therapeutics to achieve the consultation goal of our partners.
Our research and development analyst understands the oncology realm to create value-based decisions and help clients achieve better oncological R&D endeavors. Any oncological drug's journey through pre-clinical and clinical development is done by assessing the same parameters of other candidates already in the space. DelveInsight’s insight-packed oncological reports provide clarity on uncertainties and challenge blind spots to provide timely intelligence to the company.
DelveInsight’s Oncological Pipeline Assessment promises an overarching view of cancer therapies, their clinical trials, as well as each and every highlight of the cancer therapeutics landscape in a report format. Encompassing oncology ready reports already present in our Report Store, our Pipeline Assessment report type provides insights across therapies, MoAs, Drugs, APIs, as well as Launch Insights of drugs in late-stage of development to provide an understanding of their launch timelines and strategies.
We welcome you to discuss your business-related concerns and we can together find the best possible solution to help you proceed further in the Biotechnology and Pharma market.
Ms. Cheryl Anne Abranches has managerial experience of more than 10 years in providing strategic decision support to top global pharmaceuticals. She holds exceptional experience in project management and business development, having worked with cross-cultural teams. Her expertise lies in the field of Commercial Analytics and Sales Force Effectiveness. Schedule a meet with Cheryl and assess how DelveInsight’s Consulting portfolio can drive your company to excellence!
Mr. Ribhu is an Experienced International Business Manager with a demonstrated history of working in the market research industry. A successful professional with more than 8 years of experience in Sales and Marketing Management. An astute professional with expertise in the areas of Business Development, Demand Generation, Account Management, Client Servicing & Team Management.
The Festival of Biologics conference and exhibition will take place from 2nd to 4th of November, 2022 with an in-person meeting in the surreal city of Basel, Switzerland.
